Clinical Trial Update: A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the effectiveness of Imiquimod 5% cream in superficial basal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Imiquimod 5% cream (Imiquimod)

Snippet

Sponsor: MEDA Pharma GmbH & Co. KG | Conditions: Basal Cell Carcinoma | Phase 3 | Status: COMPLETED